−120
Dyne Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−154
FY23:
−188
FY24:
−292
FY25:
−403
Change from FY21 to FY25
millions USD
FY21:
−138
FY22:
87.2
FY23:
83.3
FY24:
−204
FY25:
−28.8
Change from FY21 to FY25
millions USD
FY21:
158
FY22:
37.4
FY23:
54.3
FY24:
810
FY25:
890
millions USD
FY21:
−99.6
FY22:
−29.1
FY23:
−50.5
FY24:
313
FY25:
458
(positive)
Change from FY21 to FY25
millions USD
FY21:
−123
FY22:
−157
FY23:
−189
FY24:
−295
FY25:
−405
All amounts in millions USD